Cod Liver Oil Market - Global Forecast 2026-2032

The Cod Liver Oil Market size was estimated at USD 115.75 million in 2025 and expected to reach USD 131.67 million in 2026, at a CAGR of 11.10% to reach USD 241.89 million by 2032.

Cod liver oil stands as one of the most potent and enduring nutritional supplements, revered for its unique composition of omega-3 fatty acids-particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)-along with rich concentrations of vitamins A and D. EPA and DHA have been scientifically recognized for contributing to the maintenance of normal heart function, provided daily intake levels are met. Such established health claims have cemented cod liver oil’s reputation as a cornerstone of preventive and functional nutrition provisions for diverse populations. Likewise, its status as a source of vitamin A and vitamin D underscores its critical role in supporting immune function and skeletal health, as regulated by European health claim standards.

In recent years, cod liver oil has experienced a renaissance amid surging consumer interest in holistic wellness and natural remedies. A growing demographic values scientifically validated supplements that address nutritional gaps and support long-term health trajectories. Concurrently, advancements in manufacturing and digital marketing strategies have enabled producers to highlight traceability, purity, and tailored formulations, directly engaging health-conscious audiences through e-commerce platforms and personalized communication channels. This blend of time-honored benefits and modern delivery mechanisms positions cod liver oil at the forefront of the evolving nutraceutical landscape.

The cod liver oil market is undergoing profound transformation driven by a convergence of sustainability initiatives, regulatory evolution, and technological breakthroughs. Producers and ingredient suppliers are increasingly prioritizing eco-responsible sourcing, implementing traceable fishing practices, and pursuing certifications that reinforce environmental stewardship. At the same time, regulatory bodies have intensified scrutiny over product integrity, mandating rigorous quality and safety standards that shape formulation and labeling compliance. These dual pressures are redefining supply chain architecture, prompting stakeholders to integrate blockchain traceability and third-party testing protocols to meet both consumer expectations and compliance obligations.

Simultaneously, innovation is catalyzing new growth avenues across product development and consumer engagement. Advanced extraction and molecular distillation techniques optimize bioavailability while preserving delicate nutrient profiles. Personalized nutrition platforms and direct-to-consumer models are rising in prominence, enabling precise dosage customization and subscription-based fulfillment. Furthermore, strategic collaborations between research institutions and manufacturers are accelerating clinical validation of novel cod liver oil formulations, reinforcing confidence among healthcare professionals and end users alike. These transformative currents collectively signal a dynamic market evolution poised to deliver enhanced efficacy and differentiated value propositions.

In 2025, the United States introduced a universal tariff of 10% on dietary supplement imports from non-exempt countries and further implemented country-specific reciprocal tariffs ranging from 11% to 50%, effective April, with a temporary pause on most reciprocal duties except those targeting China. These measures stack upon pre-existing Section 301 tariffs of 25% on Chinese-origin goods, generating a potential cumulative levy of 145% for products sourced from China. As cod liver oil frequently relies on global supply chains, these layered duties have significantly tightened cost structures for importers and end-market stakeholders.

Under the U.S. Harmonized Tariff Schedule (HTS), cod liver oil derived specifically from cod (HTS 1504.10.20.00) benefits from a zero percent general rate of duty, while other fish-liver oils (HTS 1504.10.40.00) carry a standard 2.5% ad valorem levy. However, when augmented by universal and reciprocal levies, effective import tariffs for non-exempt jurisdictions can escalate to 12.5% for non-cod fish-liver oils and 10% for cod liver oil, irrespective of baseline duty exemptions. Should shipment origins fall under retaliatory Section 301 designations, additional 25% charges apply, amplifying landed costs and compelling buyers to reassess supplier geographies.

These intensified tariff burdens have prompted market participants to rethink procurement strategies, diversify sourcing toward trade ally nations, and expedite nearshore partnerships that mitigate duty exposure. Concurrently, some suppliers are exploring tariff classification management and value-added processing to leverage duty-free thresholds and preferential trade agreements. As a result, cod liver oil supply chains have become increasingly fluid and strategic, reflecting a cautious recalibration in response to evolving trade policy dynamics.

The cod liver oil sector exhibits distinct consumer preferences aligned with key segmentation drivers. Products are available predominantly in liquid oil and softgel capsule formats, each catering to divergent dosing styles and user experiences. Liquid variants are often favored for pediatric and tailored adult applications where flavor-masking technologies enhance palatability, while softgel capsules appeal to convenience-oriented consumers seeking precise, pre-measured daily intake without sensory considerations.

Distribution channels extend across online retail platforms, brick-and-mortar pharmacies and drugstores, specialty health establishments, and large-scale supermarkets and hypermarkets. Each channel presents unique engagement mechanics: digital retail enables subscription and sample-based promotions; pharmacies emphasize professional recommendation and trust; specialty stores deliver curated brand stories; and supermarkets drive volume through end-aisle visibility and promotional placement. Formulation innovation spans flavored cod liver oils, high vitamin D enriched blends, organic cold-pressed variants, and standard emulsified offerings. End-user categories include adult segments-further differentiated by gender-geriatric populations with heightened bone and joint health concerns, and pediatric cohorts where kid-friendly options prevail. In addition to human applications, veterinary use emerges as a niche growth area, reflecting expanding interest in animal health supplementation.

In the Americas, regulatory oversight under the Dietary Supplement Health and Education Act of 1994 (DSHEA) has fostered a robust supplement industry reinforced by Good Manufacturing Practices and clear labeling standards. The United States market thrives on claims permitted under structure/function guidelines, yet faces tightening scrutiny on safety reporting and ingredient transparency. Canada and Latin American countries exhibit growing cod liver oil demand driven by rising middle-class health investments and an increasing focus on preventive nutrition.

The Europe, Middle East & Africa (EMEA) region is characterized by stringent health claim authorisation governed by Regulation (EC) No 1924/2006, requiring scientific substantiation and EFSA approval for claims such as sources of omega-3 fatty acids and vitamin D content. European markets place premium value on sustainability certifications (e.g., MSC), while the Middle East leverages regulatory harmonisation initiatives under GCC guidelines. In Africa, expanding awareness initiatives and NGO-led nutrition programs are enhancing access to cod liver oil supplements in urban and peri-urban centers.

Asia-Pacific exemplifies rapid consumer transition toward preventive health, propelled by a burgeoning wellness economy and digital commerce infrastructure. Australia and New Zealand maintain rigorous therapeutic goods regulations, aligning cod liver oil classification with nutraceutical frameworks. In Southeast Asia, e-tail channels and cross-border platforms are unlocking new consumer segments. Meanwhile, emerging markets in India and China are increasingly receptive to Western supplement paradigms, although import tariffs and local manufacturing incentives shape regional sourcing and distribution strategies.

The global cod liver oil market features a mix of legacy brands and innovative challengers, with Nordic Naturals, Carlson Laboratories, Seven Seas Ltd., LYSI hf, and Solgar Inc. among the most influential players. These companies command significant brand equity through commitments to sustainability, high-purity protocols, and diverse product portfolios. Emerging entrants and private-label suppliers continue to intensify competitive pressure by targeting price-sensitive segments and online ecosystems.

Carlson Laboratories has distinguished itself through stringent independent testing and transparent International Fish Oil Standards certifications, offering lemon-flavored liquids, precision softgels, and specialty child formulations that cater to both taste and potency priorities. NOW Foods competes on mass-market accessibility, deploying aggressive value pricing across major retailers and leveraging cGMP compliance to maintain essential quality while capturing high-volume channels. Nordic Naturals has refined palatability with proprietary flavor technology, integrally aligning pediatric and family segments with scientific rigor and professional endorsements.

Strategic movements in 2022 and 2024 underscore ongoing industry consolidation and product innovation. Orkla Health’s acquisition of Vesterälen Marine Olje AS fortified its upstream raw material capabilities, reinforcing regional processing autonomy and resource stewardship. In January 2024, Wiley’s Finest launched a new fortified cod liver oil formula enriched with vitamins D3, E, and omega-3s to address cognitive, immune, and ocular health applications. Seven Seas, backed by Procter & Gamble, remains a heritage brand leveraging extensive R&D history and a broad multichannel distribution matrix.

Industry leaders should prioritize supply chain resilience through diversified sourcing and tariff-aware logistics strategies. By engaging suppliers across multiple trade-agreement-friendly regions and adopting agile procurement systems, companies can mitigate cost volatility from tariff fluctuations and ensure consistent raw material availability. Integrating advanced demand-planning tools will further strengthen inventory management and responsiveness to shifting consumer preferences.

To navigate evolving regulatory landscapes, market participants must invest in comprehensive compliance frameworks. This entails systematic monitoring of global health claim authorisation processes, proactive ingredient risk assessments, and rigorous documentation aligned with regional requirements. Collaboration with regulatory consultants and leveraging digital labeling solutions can streamline the adaptation of packaging, claims, and safety dossiers to new standards.

Innovation in product formulation and digital engagement remains a critical differentiator. Developing tailored cod liver oil blends-such as high vitamin D products, flavor-masked liquids for pediatric use, and enhanced bioavailability softgels-will meet nuanced consumer demands. Concurrently, leveraging data-driven marketing, subscription models, and telehealth partnerships can extend brand reach and bolster long-term customer loyalty. Strategic investments in sustainable packaging and circular economy initiatives will resonate with environmentally conscious audiences and enhance market positioning.

This research integrates both secondary and primary methodologies to deliver a holistic market perspective. Secondary analysis encompasses a review of regulatory documents, industry publications, tariff schedules, and peer-reviewed studies on cod liver oil health benefits. Key data sources include government harmonized tariff schedules, EFSA and FDA guidelines, and authenticated trade bulletins to ensure factual rigor.

Primary research involved in-depth interviews with supply chain executives, product development specialists, and distribution channel leaders to validate emerging trends and gather qualitative insights. Data triangulation was achieved by cross-referencing expert feedback with market intelligence platforms and field observations. Analytical frameworks such as SWOT and Porter’s Five Forces were employed to contextualize competitive dynamics and strategic imperatives, underpinning the robust conclusions presented in this report.

The collective insights reveal that cod liver oil remains a cornerstone of the nutraceutical sector, driven by its unique nutritional profile, evolving consumer preferences, and dynamic regulatory environments. Sustainability demands and trade policy shifts are reshaping sourcing strategies, while technological advancements and innovative formulations deliver differentiated value. Regional nuances-from DSHEA-governed North America to EFSA-citizen Europe and digitally enabled Asia-Pacific-underscore the importance of localized approaches.

For stakeholders, the imperative lies in harmonizing supply chain agility, compliance excellence, and consumer-centric innovation. By aligning strategic priorities with the detailed market intelligence presented here, industry leaders can capitalize on growth opportunities, mitigate emerging risks, and establish enduring competitive advantages in the global cod liver oil marketplace.

To explore how this comprehensive market research can directly support your strategic objectives and secure a competitive edge, please reach out to Ketan Rohom, Associate Director of Sales & Marketing, for tailored guidance on report acquisition. With a deep understanding of industry dynamics and a commitment to delivering actionable data, Ketan can assist in customizing access to the insights most relevant to your organization’s goals. Partner with our expert team to obtain the full breadth of analysis, and empower your decision-making with the definitive cod liver oil market intelligence package.